Literature DB >> 18294825

Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin.

Wei Sun1, Shirui Mao, Dan Mei, Thomas Kissel.   

Abstract

Polyelectrolyte complexes (PEC) formed from chitosan derivatives and enoxaparin were prepared and parameters influencing complex formation were characterized. Dynamic light scattering (DLS) and laser doppler anemometry (LDA) were used to study the complexation process. Surface morphology of the PECs was observed with atomic force microscopy (AFM). The PEC formation process was influenced by a variety of parameters, including the system pH, polymer/enoxaparin mass ratio, polymer molecular weight, concentration and structure. Soluble complexes in the size range of 200-500 nm with spherical morphology could be obtained at optimized polymer/enoxaparin ratios in the pH range of 3.0-6.5, with positive charge and drug encapsulation efficiency of approximately 90%. An increase in ionic strength of the medium accelerated the dissociation of chitosan/enoxaparin complexes. In contrast, chitosan thiolation, methylation and PEGylation significantly improved the stability of the complexes. Physicochemical properties of the PECs, including particle size, charge density and morphology, could be modified by using different chitosan derivatives. On the basis of our results, we suggest that interactions involved in PEC formation were partly electrostatic in nature, involving the positively charged chitosan derivatives and the negatively charged enoxaparin at pH values in the vicinity of the pKa interval of the two polymers. Oral absorption of the polyelectrolyte nanocomplexes will be studied in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294825     DOI: 10.1016/j.ejpb.2008.01.016

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.

Authors:  Tianzhi Yang; Divine Nyiawung; Alexandra Silber; Jiukuan Hao; Leanne Lai; Shuhua Bai
Journal:  AAPS PharmSciTech       Date:  2012-09-28       Impact factor: 3.246

2.  Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCl for pediatric use: in-vitro/in-vivo evaluation and histopathological examination.

Authors:  Rabab Kamel; Haidy Abbas; Mona El-Naa
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

3.  Superstructure based on β-CD self-assembly induced by a small guest molecule.

Authors:  Frederico B De Sousa; Ana C Lima; Angelo M L Denadai; Cleber P A Anconi; Wagner B De Almeida; Willian T G Novato; Hélio F Dos Santos; Chester L Drum; Robert Langer; Rubén D Sinisterra
Journal:  Phys Chem Chem Phys       Date:  2012-01-10       Impact factor: 3.676

4.  Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates.

Authors:  Angela Viehof; Alf Lamprecht
Journal:  Pharm Res       Date:  2013-05-07       Impact factor: 4.200

5.  Ternary polymeric nanoparticles for oral siRNA delivery.

Authors:  Jing Zhang; Chunbai He; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

Review 6.  Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.

Authors:  Fahad Akhtar; Xinyu Wan; Gang Wu; Samuel Kesse; Shaoda Wang; Shuying He
Journal:  Molecules       Date:  2018-07-18       Impact factor: 4.411

7.  Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation.

Authors:  Bettina Ralay-Ranaivo; Didier Desmaële; Elsa P Bianchini; Elise Lepeltier; Claudie Bourgaux; Delphine Borgel; Thierry Pouget; Jean François Tranchant; Patrick Couvreur; Ruxandra Gref
Journal:  J Control Release       Date:  2014-08-13       Impact factor: 9.776

8.  Serum Albumin-Peptide Conjugates for Simultaneous Heparin Binding and Detection.

Authors:  Qing Liu; Salla Välimäki; Ahmed Shaukat; Boxuan Shen; Veikko Linko; Mauri A Kostiainen
Journal:  ACS Omega       Date:  2019-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.